27883264|t|Mucosa - associated biohydrogenating microbes protect the simulated colon microbiome from stress associated with high concentrations of poly-unsaturated fat
27883264|a|Polyunsaturated fatty acids (PUFAs) may affect colon microbiome homeostasis by exerting (specific) antimicrobial effects and/or interfering with mucosal biofilm formation at the gut mucosal interface. We used standardized batch incubations and the Mucosal-Simulator of the Human Microbial Intestinal Ecosystem (M-SHIME) to show the in vitro luminal and mucosal effects of the main PUFA in the Western diet, linoleic acid (LA). High concentrations of LA were found to decrease butyrate production and Faecalibacterium prausnitzii numbers dependent on LA biohydrogenation to vaccenic acid (VA) and stearic acid (SA). In faecal batch incubations, LA biohydrogenation and butyrate production were positively correlated and SA did not inhibit butyrate production. In the M-SHIME, addition of a mucosal environment stimulated biohydrogenation to SA and protected F. prausnitzii from inhibition by LA. This was probably due to the preference of two biohydrogenating genera Roseburia and Pseudobutyrivibrio for the mucosal niche. Co-culture batch incubations using Roseburia hominis and F. prausnitzii validated these observations. Correlations networks further uncovered the central role of Roseburia and Pseudobutyrivibrio in protecting luminal and mucosal SHIME microbiota from LA - induced stress. Our results confirm how cross-shielding interactions provide resilience to the microbiome and demonstrate the importance of biohydrogenating, mucosal bacteria for recovery from LA stress.
27883264	0	6	Mucosa	T031	C0026727
27883264	9	19	associated	T080	C0332281
27883264	20	45	biohydrogenating microbes	T001	C0445623
27883264	68	73	colon	T204	C3888384
27883264	74	84	microbiome	T001	C1956108
27883264	90	96	stress	T033	C0038435
27883264	97	112	associated with	T080	C0332281
27883264	113	132	high concentrations	T081	C1446561
27883264	136	156	poly-unsaturated fat	T109,T168	C2362518
27883264	157	184	Polyunsaturated fatty acids	T109,T123	C0032615
27883264	186	191	PUFAs	T109,T123	C0032615
27883264	204	209	colon	T204	C3888384
27883264	210	220	microbiome	T001	C1956108
27883264	221	232	homeostasis	T038	C0019868
27883264	236	244	exerting	T040	C0015264
27883264	246	254	specific	T080	C0205369
27883264	256	269	antimicrobial	T195	C0003232
27883264	270	277	effects	T080	C1280500
27883264	302	309	mucosal	T031	C0026727
27883264	310	317	biofilm	T167	C1561572
27883264	318	327	formation	T169	C1522492
27883264	335	356	gut mucosal interface	T023	C0836209
27883264	366	396	standardized batch incubations	T059	C1439852
27883264	405	466	Mucosal-Simulator of the Human Microbial Intestinal Ecosystem	T170	C0282574
27883264	468	475	M-SHIME	T170	C0282574
27883264	489	497	in vitro	T080	C1533691
27883264	498	505	luminal	T030	C0524461
27883264	510	517	mucosal	T031	C0026727
27883264	518	528	effects of	T080	C1704420
27883264	538	542	PUFA	T109,T123	C0032615
27883264	550	562	Western diet	T061	C3849996
27883264	564	577	linoleic acid	T109,T121,T123	C0023749
27883264	579	581	LA	T109,T121,T123	C0023749
27883264	584	603	High concentrations	T081	C1446561
27883264	607	609	LA	T109,T121,T123	C0023749
27883264	624	632	decrease	T081	C0547047
27883264	633	641	butyrate	T109	C0006521
27883264	642	652	production	T169	C0205245
27883264	657	685	Faecalibacterium prausnitzii	T007	C0317558
27883264	707	709	LA	T109,T121,T123	C0023749
27883264	710	726	biohydrogenation	T070	C0020286
27883264	730	743	vaccenic acid	T109	C0301702
27883264	745	747	VA	T109	C0301702
27883264	753	765	stearic acid	T109,T121	C0038229
27883264	767	769	SA	T109,T121	C0038229
27883264	775	781	faecal	T031	C0015733
27883264	782	799	batch incubations	T059	C1439852
27883264	801	803	LA	T109,T121,T123	C0023749
27883264	804	820	biohydrogenation	T070	C0020286
27883264	825	833	butyrate	T109	C0006521
27883264	834	844	production	T169	C0205245
27883264	850	871	positively correlated	T080	C1707520
27883264	876	878	SA	T109,T121	C0038229
27883264	887	894	inhibit	T052	C3463820
27883264	895	903	butyrate	T109	C0006521
27883264	904	914	production	T169	C0205245
27883264	923	930	M-SHIME	T170	C0282574
27883264	946	953	mucosal	T031	C0026727
27883264	954	965	environment	T082	C0014406
27883264	966	976	stimulated	T070	C1948023
27883264	977	993	biohydrogenation	T070	C0020286
27883264	997	999	SA	T109,T121	C0038229
27883264	1014	1028	F. prausnitzii	T007	C0317558
27883264	1034	1044	inhibition	T052	C3463820
27883264	1048	1050	LA	T109,T121,T123	C0023749
27883264	1081	1091	preference	T078	C0558295
27883264	1099	1115	biohydrogenating	T070	C0020286
27883264	1116	1122	genera	T185	C1708235
27883264	1123	1132	Roseburia	T007	C0995401
27883264	1137	1155	Pseudobutyrivibrio	T007	C1012458
27883264	1164	1171	mucosal	T031	C0026727
27883264	1179	1189	Co-culture	T059	C0282547
27883264	1190	1207	batch incubations	T059	C1439852
27883264	1214	1231	Roseburia hominis	T007	C1667633
27883264	1236	1250	F. prausnitzii	T007	C0317558
27883264	1251	1260	validated	T062	C1519941
27883264	1267	1279	observations	T062	C0302523
27883264	1281	1293	Correlations	T080	C1707520
27883264	1294	1302	networks	T169	C1882071
27883264	1341	1350	Roseburia	T007	C0995401
27883264	1355	1373	Pseudobutyrivibrio	T007	C1012458
27883264	1388	1395	luminal	T030	C0524461
27883264	1400	1424	mucosal SHIME microbiota	T059	C3496041
27883264	1430	1432	LA	T109,T121,T123	C0023749
27883264	1435	1449	induced stress	T033	C0038435
27883264	1455	1462	results	T169	C1274040
27883264	1475	1503	cross-shielding interactions	T169	C1704675
27883264	1530	1540	microbiome	T001	C1956108
27883264	1561	1571	importance	T080	C3898777
27883264	1575	1591	biohydrogenating	T070	C0020286
27883264	1593	1600	mucosal	T031	C0026727
27883264	1601	1609	bacteria	T007	C0004611
27883264	1614	1622	recovery	T052	C0237820
27883264	1628	1630	LA	T109,T121,T123	C0023749
27883264	1631	1637	stress	T033	C0038435